{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T01:27:49Z","timestamp":1759541269646},"reference-count":39,"publisher":"Impact Journals, LLC","issue":"29","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2015,9,29]]},"DOI":"10.18632\/oncotarget.4950","type":"journal-article","created":{"date-parts":[[2015,9,29]],"date-time":"2015-09-29T17:43:03Z","timestamp":1443548583000},"page":"28223-28237","source":"Crossref","is-referenced-by-count":18,"title":["WT1-mediated repression of the proapoptotic transcription factor ZNF224 is triggered by the BCR-ABL oncogene"],"prefix":"10.18632","volume":"6","author":[{"given":"Giorgia","family":"Montano","sequence":"first","affiliation":[{"name":"Department of Molecular Medicine and Medical Biotechnology University of Naples Federico II, Naples, Italy"},{"name":"Department of Haematology and Transfusion Medicine, BioMedical Center, Lund University, Lund, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karina","family":"Vidovic","sequence":"additional","affiliation":[{"name":"Department of Haematology and Transfusion Medicine, BioMedical Center, Lund University, Lund, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Palladino","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine and Medical Biotechnology University of Naples Federico II, Naples, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Cesaro","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine and Medical Biotechnology University of Naples Federico II, Naples, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaetano","family":"Sodaro","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine and Medical Biotechnology University of Naples Federico II, Naples, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Concetta","family":"Quintarelli","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Biagio","family":"De Angelis","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Santa","family":"Errichiello","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabrizio","family":"Pane","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Izzo","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine and Medical Biotechnology University of Naples Federico II, Naples, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michela","family":"Grosso","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine and Medical Biotechnology University of Naples Federico II, Naples, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Urban","family":"Gullberg","sequence":"additional","affiliation":[{"name":"Department of Haematology and Transfusion Medicine, BioMedical Center, Lund University, Lund, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Costanzo","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine and Medical Biotechnology University of Naples Federico II, Naples, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2015,7,22]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0014-5793(02)03783-3","article-title":"A novel zinc finger transcriptional repressor, ZNF224, interacts with the negative regulatory element (AldA-NRE) and inhibits gene expression","volume":"534","author":"Izzo","year":"2003","journal-title":"FEBS Letters"},{"key":"2","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.gene.2005.06.021","article-title":"The Kruppel-like zinc finger protein ZNF224 represses aldolase A gene transcription by interacting with the KAP-1 corepressor protein","volume":"359","author":"Izzo","year":"2005","journal-title":"Gene"},{"key":"3","first-page":"8623","article-title":"The KAP1 corepressor functions to coordinate the assembly of de novo HP1 demarcated microenviroments of heterochromatin required for KRAB Zinc Finger Protein-mediated transcriptional repression. Mol","volume":"26","author":"Schultz","year":"2006","journal-title":"Cell Biol"},{"key":"4","doi-asserted-by":"crossref","first-page":"32321","DOI":"10.1074\/jbc.M109.043349","article-title":"The Kruppel-like zinc finger protein ZNF224 recruits the arginine methyltransferasePRMT5 on the transcriptional repressor complex of the aldolase A gene","volume":"284","author":"Costanzo","year":"2009","journal-title":"J. Biol. Chem"},{"key":"5","doi-asserted-by":"crossref","first-page":"3544","DOI":"10.1093\/hmg\/ddq270","article-title":"Biochemical and functional interaction between ZNF224 and ZNF255, two members of the Kruppel-like zinc-finger protein family and WT1 protein isoforms","volume":"19","author":"Costanzo","year":"2010","journal-title":"Hum. Mol. Genet"},{"key":"6","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/sj.leu.2404624","article-title":"A tumor suppressor and oncogene: the WT1 story","volume":"21","author":"Minden","year":"2007","journal-title":"Leukemia"},{"key":"7","first-page":"405","article-title":"Expression of the Wilms\u2019 tumor gene (WT1) in human leukemias","volume":"6","author":"Saunders","year":"1992","journal-title":"Leukemia"},{"key":"8","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/nrc3002","article-title":"Wilms\u2019 tumours: about tumour suppressor genes, an oncogene and a chameleon gene","volume":"11","author":"Huff","year":"2011","journal-title":"Nature Reviews Cancer"},{"key":"9","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.4161\/cc.5.12.2807","article-title":"WT1 influences apoptosis through transcriptional regulation of Bcl-2 family members","volume":"5","author":"Loeb","year":"2006","journal-title":"Cell Cycle"},{"key":"10","doi-asserted-by":"crossref","first-page":"4217","DOI":"10.1038\/sj.onc.1209455","article-title":"Antiapoptotic function of 17AA(+)WT1 (Wilms\u2019 tumor gene) isoforms on the intrinsic apoptosis pathway","volume":"25","author":"Shirakata","year":"2006","journal-title":"Oncogene"},{"key":"11","doi-asserted-by":"crossref","first-page":"4695","DOI":"10.1182\/blood-2005-10-4025","article-title":"The antiapoptotic gene A1\/BFL1 is a WT1 target gene that mediates granulocytic differentiation and resistance to chemotherapy","volume":"107","author":"Loeb","year":"2006","journal-title":"Blood"},{"key":"12","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1038\/leu.2010.68","article-title":"WT1 protein is a transcriptional activator of the antiapoptotic bag3 gene","volume":"24","author":"Costanzo","year":"2010","journal-title":"Leukemia"},{"key":"13","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1093\/hmg\/ddt027","article-title":"Role of WT1-ZNF224 interaction in the expression of apoptosis-regulating genes","volume":"22","author":"Costanzo","year":"2013","journal-title":"Hum. Mol. Genet"},{"key":"14","doi-asserted-by":"crossref","first-page":"3343","DOI":"10.1182\/blood.V96.10.3343","article-title":"The molecular biology of chronic myeloid leukemia","volume":"96","author":"Melo","year":"2000","journal-title":"Blood"},{"key":"15","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1002\/j.1460-2075.1994.tb06319.x","article-title":"Bcr-Abl oncoproteins bind directly to activators of the Ras signaling pathway","volume":"13","author":"Pawson","year":"1994","journal-title":"EMBO J"},{"key":"16","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/328342a0","article-title":"Altered adhesive interactions with marrow stroma of haematopoietic progenitor cells in chronic myeloid leukaemia","volume":"328","author":"Greaves","year":"1987","journal-title":"Nature"},{"key":"17","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1182\/blood.V83.8.2038.2038","article-title":"Inhibition of apoptosis by BCR-ABL in chronic myeloid leukemia","volume":"83","author":"Jones","year":"1994","journal-title":"Blood"},{"key":"18","first-page":"1179","article-title":"Bcr-Abl maintains resistance of chronic myelogenous leukemia cells to apoptotic cell death","volume":"83","author":"Cotter","year":"1994","journal-title":"Blood"},{"key":"19","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1038\/sj.leu.2404924","article-title":"Deregulation of the Wilms\u2019 tumour gene 1 protein (WT1) by BCR\/ABL1 mediates resistance to imatinib in human leukaemia cells","volume":"21","author":"Gullberg","year":"2007","journal-title":"Leukemia"},{"key":"20","doi-asserted-by":"crossref","first-page":"3634","DOI":"10.1182\/blood-2011-03-341073","article-title":"SHP-1 expression accounts for resistance to imatinib treatment in Philadelphia Chromosome-positive cells derived from patients with chronic myeloid leukemia","volume":"118","author":"Russo","year":"2011","journal-title":"Blood"},{"key":"21","doi-asserted-by":"crossref","first-page":"5531","DOI":"10.1128\/MCB.15.10.5531","article-title":"Structural and signaling requirements for BCR-ABL-mediated tansformation and inhibition of apoptosis","volume":"15","author":"Pendergast","year":"1995","journal-title":"Mol. Cell. Biol"},{"key":"22","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/nrc1567","article-title":"Mechanisms of BCR-ABL in the pathogenesis of chronic myelogenous leukaemia","volume":"5","author":"Ren","year":"2005","journal-title":"Nat. Rev. Cancer"},{"key":"23","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1182\/blood-2013-05-501569","article-title":"European LeukemiaNet recommendations for the management of chronic myeloid leukemia","volume":"122","author":"Kantarjian","year":"2013","journal-title":"Blood"},{"key":"24","doi-asserted-by":"crossref","first-page":"9436","DOI":"10.1158\/0008-5472.CAN-05-0972","article-title":"Low-level expression of proapoptotic Bcl-2-interacting mediator in leukemic cells in patients with chronic myeloid leukemia: role of BCR\/ABL, characterization of underlying signaling pathways, and reexpression by novel pharmacologic compounds","volume":"65","author":"Valent","year":"2005","journal-title":"Cancer Res"},{"key":"25","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1038\/sj.onc.1208421","article-title":"Direct transcriptional regulation of Bim by FoxO3a mediates STI571-induced apoptosis in Bcr-Abl-expressing cells","volume":"24","author":"Lam","year":"2005","journal-title":"Oncogene"},{"key":"26","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/leu.2012.220","article-title":"Transcriptional suppression of BACH2 by the Bcr-Abl oncoprotein is mediated by PAX5","volume":"27","author":"Melo","year":"2013","journal-title":"Leukemia"},{"key":"27","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1038\/leu.2010.33","article-title":"Wilms\u2019 tumor gene 1 protein represses the expression of the tumor suppressor interferon regulatory factor 8 in human hematopoietic progenitors and in leukemic cells","volume":"24","author":"Gullberg","year":"2010","journal-title":"Leukemia"},{"key":"28","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1242\/dev.121.3.867","article-title":"Repression of Pax-2 by WT1 during normal kidney development","volume":"121","author":"Dressler","year":"1995","journal-title":"Development"},{"key":"29","first-page":"447","article-title":"The paired-box transcription factor, PAX2, positively modulates expression of the Wilms\u2019 tumor suppressor gene (WT1)","volume":"13","author":"Pelletier","year":"1996","journal-title":"Oncogene"},{"key":"30","doi-asserted-by":"crossref","first-page":"8145","DOI":"10.1038\/sj.onc.1206997","article-title":"WT1 is a modifier of the Pax2 mutant phenotype: cooperation and interaction between WT1 and Pax2","volume":"22","author":"Pelletier","year":"2003","journal-title":"Oncogene"},{"key":"31","doi-asserted-by":"crossref","first-page":"7519","DOI":"10.1158\/1078-0432.CCR-09-1068","article-title":"Mechanisms of Resistance to Imatinib and Second-Generation Tyrosine Inhibitors in Chronic Myeloid Leukemia","volume":"15","author":"Apperley","year":"2009","journal-title":"Clin. Cancer. Res"},{"key":"32","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1182\/blood-2008-03-144790","article-title":"Molecular biology of BCR-ABL1-positive chronic myeloid leukemia","volume":"113","author":"Cortes","year":"2009","journal-title":"Blood"},{"key":"33","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1038\/sj.leu.2402303","article-title":"Forced expression of the Wilms tumor 1 (WT1) gene inhibits proliferation of human hematopoietic CD34+ progenitor cells","volume":"15","author":"Gullberg","year":"2001","journal-title":"Leukemia"},{"key":"34","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.leukres.2013.11.006","article-title":"Selective strong synergism of Ruxolitinib and second generation tyrosine kinase inhibitors to overcome bone marrow stroma related drug resistance in chronic myelogenous leukemia","volume":"38","author":"Saglio","year":"2014","journal-title":"Leuk. Res"},{"key":"35","first-page":"503","article-title":"Gene quantification using real-time quantitative PCR: an emerging technology hits the mainstream. Exp","volume":"30","author":"Ginzinger","year":"2002","journal-title":"Hematol"},{"key":"36","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1038\/sj.leu.2403135","article-title":"Standardization and quality control studies of \u2018real time\u2019 quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia-A Europe Against Cancer program","volume":"17","author":"De Micheli","year":"2003","journal-title":"Leukemia"},{"key":"37","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1182\/blood-2006-01-0092","article-title":"Monitoring CML patients responding to treatment with tyrosine kinase inhibitors: Review and recommendations for harmonizing current methodology for detecting BCR-ABL transcripts and kinase domain mutations and for expressing results","volume":"108","author":"Hehlmann","year":"2006","journal-title":"Blood"},{"key":"38","doi-asserted-by":"crossref","first-page":"3330","DOI":"10.1182\/blood-2008-04-150680","article-title":"Desirable performance characteristics for BCR-ABL measurement on an international reporting scale to allow consistent interpretation of individual patient response and comparison of response rates between clinical trials","volume":"112","author":"Lynch","year":"2008","journal-title":"Blood"},{"key":"39","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1038\/leu.2009.168","article-title":"Harmonization of molecular monitoring of CML therapy in Europe","volume":"23","author":"Hochhaus","year":"2009","journal-title":"Leukemia"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.4950","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,22]],"date-time":"2022-05-22T12:24:32Z","timestamp":1653222272000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.4950"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,22]]},"references-count":39,"journal-issue":{"issue":"29","published-print":{"date-parts":[[2015,9,29]]}},"alternative-id":["4950","26320177"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.4950","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,22]]}}}